GenScript Biotech Corporation, a provider of life-science research tools and services, has expanded its cGMP manufacturing capacity for sgRNA and non-viral DNA payloads with a new, state-of-the-art facility in Zhenjiang, Jiangsu, China. The latest expansion provides biopharma companies and gene and cell therapeutic discovery startups with components needed to advance novel therapies from the bench to the clinic. The move positions GenScript as a top supplier with the capacity to help shorten ...